Servier Pharmaceuticals · 10 hours ago
Global Biometrics Intern
Boston, KY
Internship
Onsite
Intern
$44/hr - $44/hrServier Pharmaceuticals is a Boston-based biopharmaceutical company focused on advancing science and addressing therapeutic areas. The Global Biometrics Intern will support statistical analyses for clinical trials and collaborate with experienced biostatisticians, gaining hands-on experience in pharmaceutical research and development.
Health CareMedicalPharmaceutical
Responsibilities
Work under the guidance of an industry statistician mentor to conduct methodology research and develop statistical packages
Implement algorithms and develop the associated workflow
Explore innovative or advanced statistical methodologies under mentorship
Document methods and results in accordance with regulatory and company standards
Present project results to colleagues and the department management at the conclusion of the summer internship
Qualification
Required
PhD student or candidate in Statistics, Biostatistics, Computer Science, Computer Engineering, or a related field
Candidates must be legally authorized to work in the United States
Strong programming or software development experience in R, Python, or a similar language
Strong statistical simulation experience
Excellent analytical, problem-solving, and communication skills
Ability to work independently and in a collaborative team environment
Company
Servier Pharmaceuticals
Servier Pharmaceuticals is a pharmaceutical company dedicated to therapeutic progress to serve patient needs.
Founded in 2018
201-500 employees
H1B Sponsorship
Servier Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (4)
2023 (4)
2022 (3)
2021 (15)
2020 (2)
Funding
Current Stage
Growth StageLeadership Team
David K. Lee
Chief Executive Officer
Pedro Crisanto
Chief Operating Officer R&D, USA
Recent News
2025-12-08
Company data provided by crunchbase